Pierre Bougneres

Endocube SAS specializes in identification, validation and selection of novel drugable targets. The firm offers its services for the diagnosis and treatment of major chronic inflammatory conditions. The company was founded Pascal Brandys and Agnès Le Saux-Narjoz in 2001 and is headquartered in Labège, France.

Annapurna Therapeutics SAS operates as a gene therapy company. Its therapy restored cardiac function and reversed pathological heart enlargement in mice that had already progressed to heart failure. The company was founded by Pierre Bougneres, Hélène Puccio, Amber Salzman, Patrick Aubourg and Ronald G. Crystal and is headquartered in Paris, France.